Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF – Get Free Report) saw a large decline in short interest in May. As of May 29th, there was short interest totaling 118,738 shares, a decline of 33.8% from the May 14th total of 179,478 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.
Shin Nippon Biomedical Laboratories Stock Performance
Shares of OTCMKTS:SBLOF opened at $7.00 on Tuesday. Shin Nippon Biomedical Laboratories has a 52 week low of $7.00 and a 52 week high of $9.16. The company’s fifty day moving average is $8.94 and its 200-day moving average is $9.62.
About Shin Nippon Biomedical Laboratories
Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS: SBLOF) is a Japan‐based contract research organization specializing in nonclinical safety assessment for the pharmaceutical, biotechnology and agrochemical industries. Established in 1978 and headquartered in Kagoshima, the company provides a range of preclinical testing services designed to support drug development from early discovery through regulatory submission. SBLOF is known for its adherence to Good Laboratory Practice (GLP) standards and its focus on high‐quality data generation and compliance.
The company’s core services include toxicology studies, pharmacokinetics and bioanalysis, safety pharmacology, pathology and genetic toxicology.
Recommended Stories
- Five stocks we like better than Shin Nippon Biomedical Laboratories
- This Golden Cross Could Send Urban Outfitters to New Highs
- Insiders Sell Top Tech Plays: Should Investors Buy, Sell, or Hold?
- Can D-Wave Hold Its Own Against 2 Fast-Growing Rivals?
- 3 AI Stocks With Moats That Could Outlast Summer Volatility
Receive News & Ratings for Shin Nippon Biomedical Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shin Nippon Biomedical Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
